AGP Limited

Generic:

Febuxostat

Therapeutic Class:

Anti-Gout

Composition:

Each Febuxin tablet contains 40 or 80 mg of febuxostat for oral administration.

Description:

Febuxin (febuxostat) is a xanthine oxidase inhibitor.

Indications:

Febuxin is indicated for the chronic management of hyperuricemia in patients with gout.

Dosage:

For treatment of hyperuricemia in patients with gout, Febuxin is recommended at 40 mg or 80 mg once daily. It can be taken without regard to food or antacid use.

The recommended starting dose of Febuxin is 40 mg once daily. For patients
who do not achieve a serum uric acid (sUA) less than 6 mg per dL after 2
weeks with 40 mg, FEBUXIN 80 mg is recommended.

Presentations:

Febuxin tab 40 mg and 80 mg is available in blister pack of 20’s.